Melamed J - Search Results

1

Oncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53-Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype Carcinomas.

He F, Melamed J, Tang MS, Huang C, Wu XR. He F, et al. Among authors: melamed j. Cancer Res. 2015 May 15;75(10):2017-28. doi: 10.1158/0008-5472.CAN-14-3067. Epub 2015 Mar 20. Cancer Res. 2015. PMID: 25795707 Free PMC article.

2

Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma.

Lotan TL, Ye H, Melamed J, Wu XR, Shih IeM, Epstein JI. Lotan TL, et al. Among authors: melamed j. Am J Surg Pathol. 2009 Jul;33(7):1037-41. doi: 10.1097/PAS.0b013e3181962dcd. Am J Surg Pathol. 2009. PMID: 19238079 Free PMC article.

3

LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion.

Li Y, Wang L, Zhang M, Melamed J, Liu X, Reiter R, Wei J, Peng Y, Zou X, Pellicer A, Garabedian MJ, Ferrari A, Lee P. Li Y, et al. Among authors: melamed j. Cancer Res. 2009 Apr 15;69(8):3332-8. doi: 10.1158/0008-5472.CAN-08-3380. Epub 2009 Apr 7. Cancer Res. 2009. PMID: 19351848 Free PMC article.

4

Expression of androgen receptor and its phosphorylated forms in breast cancer progression.

Ren Q, Zhang L, Ruoff R, Ha S, Wang J, Jain S, Reuter V, Gerald W, Giri DD, Melamed J, Garabedian MJ, Lee P, Logan SK. Ren Q, et al. Among authors: melamed j. Cancer. 2013 Jul 15;119(14):2532-40. doi: 10.1002/cncr.28092. Epub 2013 Apr 19. Cancer. 2013. PMID: 23605249 Free PMC article.

5

LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a.

Liang J, Li Y, Daniels G, Sfanos K, De Marzo A, Wei J, Li X, Chen W, Wang J, Zhong X, Melamed J, Zhao J, Lee P. Liang J, et al. Among authors: melamed j. Mol Cancer Res. 2015 Apr;13(4):681-8. doi: 10.1158/1541-7786.MCR-14-0503. Epub 2015 Jan 13. Mol Cancer Res. 2015. PMID: 25587085 Free PMC article.

6

LEF1 targeting EMT in prostate cancer invasion is mediated by miR-181a.

Liang J, Li X, Li Y, Wei J, Daniels G, Zhong X, Wang J, Sfanos K, Melamed J, Zhao J, Lee P. Liang J, et al. Among authors: melamed j. Am J Cancer Res. 2015 Feb 15;5(3):1124-32. eCollection 2015. Am J Cancer Res. 2015. PMID: 26045991 Free PMC article.

7

TPL2 Is an Oncogenic Driver in Keratocanthoma and Squamous Cell Carcinoma.

Lee JH, Lee JH, Lee SH, Do SI, Cho SD, Forslund O, Inn KS, Lee JS, Deng FM, Melamed J, Jung JU, Jeong JH. Lee JH, et al. Among authors: melamed j. Cancer Res. 2016 Nov 15;76(22):6712-6722. doi: 10.1158/0008-5472.CAN-15-3274. Epub 2016 Aug 8. Cancer Res. 2016. PMID: 27503930

8

Allelic loss on chromosome 13q in human prostate carcinoma.

Melamed J, Einhorn JM, Ittmann MM. Melamed J, et al. Clin Cancer Res. 1997 Oct;3(10):1867-72. Clin Cancer Res. 1997. PMID: 9815575

9

The cooperative prostate cancer tissue resource: a specimen and data resource for cancer researchers.

Melamed J, Datta MW, Becich MJ, Orenstein JM, Dhir R, Silver S, Fidélia-Lambert M, Kadjacsy-Balla A, Macias V, Patel A, Walden PD, Bosland MC, Berman JJ. Melamed J, et al. Clin Cancer Res. 2004 Jul 15;10(14):4614-21. doi: 10.1158/1078-0432.CCR-04-0240. Clin Cancer Res. 2004. PMID: 15269132

10

Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.

Zagzag D, Krishnamachary B, Yee H, Okuyama H, Chiriboga L, Ali MA, Melamed J, Semenza GL. Zagzag D, et al. Among authors: melamed j. Cancer Res. 2005 Jul 15;65(14):6178-88. doi: 10.1158/0008-5472.CAN-04-4406. Cancer Res. 2005. PMID: 16024619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

418 results

Search Page

Filters